The TRANSFORM-2 study found patients receiving Spravato were 70% more likely to achieve remission than those on a newly initiated oral antidepressant plus placebo
Spravato Treatment in Friendswood, TX: FDA-Approved Relief for Treatment-Resistant Depression
Find the best Spravato treatment clinic serving Friendswood, TX at Catalyst Health & Wellness — a REMS-certified Houston provider of the only FDA-approved nasal spray for treatment-resistant depression. Led by Dr. Ho, board-certified anesthesiologist and former pediatrician. Three Houston locations open Monday–Sunday, 5am–9pm.
Reset Your Brain with Spravato Friendswood
Friendswood carries a distinctive character rooted in its Quaker heritage — a community founded on the values of hard work, honest dealing, and genuine care for neighbors. Named one of CNN/Money’s “Best Places to Live” and home to a highly educated population shaped in part by proximity to NASA’s Johnson Space Center, it’s a city where people take quality seriously in every dimension of life. But that same highly informed, achievement-oriented culture can make treatment-resistant depression harder to discuss and harder to accept — especially when you’ve already tried what the research said should work, and it didn’t.
If multiple antidepressants have come and gone without delivering real, lasting relief, the problem isn’t your approach to treatment. It’s that your depression requires a different neurological pathway than every medication you’ve tried has used. At Catalyst Health & Wellness, we serve Friendswood residents — and patients from Webster, Pearland, League City, and the I-45 south corridor — as a fully REMS-certified Spravato provider. Spravato (esketamine) is the only FDA-approved nasal spray designed for treatment-resistant depression, and the National Institute of Mental Health (NIMH) — whose decades of research directly led to esketamine’s FDA approval — describes it as a treatment that “often acts rapidly, typically within a couple of hours, to relieve depression symptoms.” With Dr. Ho’s clinical expertise, thorough insurance support, and hours that work around Friendswood’s demanding schedules, Catalyst puts that scientific breakthrough within reach.
What is Spravato Therapy?
Spravato (esketamine) received FDA breakthrough therapy designation before earning full approval in 2019. That approval came after nearly 60 years of ketamine research, including pivotal NIMH-supported studies by Dr. Carlos Zarate and colleagues that transformed psychiatry’s understanding of how depression can be treated. The NIMH’s own account of this history describes the moment of FDA approval as one that “wasn’t life-changing” for patients — it was lifesaving. In 2020, the FDA extended Spravato’s approval to cover adults with major depressive disorder and active suicidal ideation. In January 2025, a third milestone: the FDA approved Spravato as a standalone monotherapy for TRD, making it the first medication ever authorized for that purpose without requiring a concurrent oral antidepressant.
Research consistently shows powerful results:
What Our Patients Say
Take the First Step Toward Healing
Book Appointment
Conditions We Treat with Spravato Therapy in Friendswood
Spravato holds FDA approval for specific clinical indications — every qualifying Friendswood patient receives a treatment with a thoroughly documented safety and efficacy record. At Catalyst Health & Wellness, we offer Spravato for:
Your Spravato Therapy Journey at Catalyst Health & Wellness
Every step of the Spravato process at Catalyst has been structured to be clear, supported, and genuinely accessible to Friendswood patients. Here's what to expect from first call through long-term care.
Step 1: Free Phone Consultation
Your first call costs nothing and commits you to nothing. A clinical team member will discuss your depression history, medication background, and current daily life. You’ll receive an honest assessment of whether Spravato is the right fit — including a direct answer if it isn’t.
Step 2: Insurance Verification & Prior Authorization
Spravato is often covered by insurance for qualifying patients, but prior authorization is nearly always required. Our team handles it entirely: benefit verification, documentation, prior auth submission, and insurer follow-up until it’s resolved. You focus on the decision; we manage the process.
Step 3: Before Your First Visit
Before your appointment, we’ll walk through everything: dietary guidelines, what to bring, how to arrange transportation, and timing notes for current medications. Nothing about your first session will be unclear when you arrive.
Step 4: Day of Treatment
Plan for approximately two to two-and-a-half hours per visit. You’ll need a designated driver or pre-arranged rideshare — driving on treatment days isn’t permitted. Come comfortable and ready to rest. That’s all the preparation required.
Step 5: Your Treatment Session
You’ll settle into a private, purpose-built treatment room — reclinable chair, soft adjustable lighting, warm blankets, noise-cancelling headphones if you want them. Spravato is self-administered as a nasal spray under direct clinical supervision. Dr. Ho’s team monitors your vital signs, blood pressure, and overall response throughout. Temporary effects — mild dissociation, light-headedness — are expected and typically resolve within the two-hour observation window.
Step 6: Recovery & Aftercare
After monitoring concludes, you’ll leave with your driver. Driving should wait until the morning after a full night’s sleep. Our team follows up between sessions to track your response and adjust anything before your next visit.
Step 7: Treatment Schedule & Maintenance
The protocol begins with twice-weekly sessions during weeks one through four, steps to once weekly in weeks five through eight, then transitions to individualized maintenance — weekly, every two weeks, or monthly — based entirely on how you’re responding. Your progress, not a preset calendar, guides the schedule.
The Science Behind Spravato for Treatment-Resistant Depression
The clinical evidence behind Spravato includes decades of foundational NIMH-supported research, two pivotal phase 3 randomized controlled trials, and nearly six years of post-approval real-world safety data.
The origin story matters here. Dr. Carlos Zarate’s NIMH research team spent years investigating ketamine’s antidepressant potential before the FDA approved esketamine in 2019. The NIMH’s account of that work notes that early clinical studies showed “patients who took esketamine with their existing antidepressants found relief quickly, and that repeat doses of esketamine could stave off depressive symptoms for over 2 months.” That early real-world observation foreshadowed what phase 3 trials later confirmed at scale.
The TRANSFORM-2 study, published in the American Journal of Psychiatry, enrolled patients with confirmed treatment-resistant depression in a double-blind comparison of flexibly-dosed Spravato plus a newly initiated oral antidepressant versus antidepressant plus placebo. Patients receiving Spravato were 70% more likely to achieve remission. Statistically significant improvement was measurable within 24 hours of the first dose — reflecting glutamate-driven synaptogenesis that no monoamine-targeting medication can replicate on that timeline.
The SUSTAIN-1 trial, published in JAMA Psychiatry, established that those gains hold with continued treatment. Patients who achieved stable remission or response were randomized to continue Spravato or transition to placebo. Those who continued treatment had significantly longer time to relapse — a hazard ratio of 0.49 (p=0.003) — confirming that maintenance treatment is a meaningful clinical investment in sustaining the improvement patients work to achieve.
Key research findings:
- Spravato drives rapid synaptogenesis and neuroplasticity in mood-regulating brain regions within hours of the first dose — the mechanism that explains its speed relative to every prior antidepressant class
- The ASPIRE I and II trials confirmed significant depressive symptom reduction within 24 hours in patients with MDD and active suicidal ideation — the first FDA-approved rapid pharmacological option for that clinical population
- NIMH-supported research established that repeat doses could stave off depressive symptoms for over two months — a durability finding now confirmed across multiple long-term studies
- The January 2025 FDA approval of esketamine as monotherapy for TRD marks the latest milestone in its expanding evidence base, adding a standalone treatment pathway for qualifying patients
Why Choose Catalyst Health & Wellness for Spravato Treatment in Friendswood
01
REMS-Certified Provider
The FDA requires all Spravato treatments to occur in a certified healthcare setting under its Risk Evaluation and Mitigation Strategy (REMS) program. Catalyst Health & Wellness holds full REMS certification across all three Houston locations. Every session Friendswood patients receive meets every federal safety standard, without exception.
02
Led by Dr. Ho – Expert Medical Care
Dr. Ho’s credentials are precisely what Spravato treatment requires. His board certification in anesthesiology means deep expertise in esketamine pharmacology, clinical dosing, and the physician-level monitoring that safe administration demands. His background as a former pediatrician shapes the entire clinic culture — patient-centered, unhurried, and genuinely focused on how treatment feels from the patient’s perspective. Friendswood patients who expect excellence in the services they rely on will find it here.
03
Insurance Navigation Support
Spravato stands apart from most advanced mental health treatments because major commercial insurance plans and Medicare frequently cover it for qualifying patients. Prior authorization is nearly always required, and the documentation process is a burden patients shouldn’t have to carry alone. Our team handles it entirely: benefit verification, prior auth submission, insurer follow-up, and appeals when needed. You focus on healing; we manage the system.
04
Whole-Person Approach
From the first call, we engage with you as a complete person — your full treatment history, your current situation, your goals, and what you’re trying to get back. Treatment plans are built around that picture and updated as your response evolves. What this means for you:
- Plans shaped by your specific history and present goals
- Ongoing adjustments based on real response data, not a fixed protocol
- Active coordination with your existing psychiatrist or prescribing physician
- Long-term engagement extending well beyond the initial treatment series
05
Extended Hours & Flexible Scheduling
Each Spravato session requires two or more hours in clinic. For Friendswood residents managing demanding professional roles — many of them connected to the NASA-JSC ecosystem or the broader aerospace and petrochemical industries in this corridor — fitting a standard weekday clinical window into the schedule is genuinely difficult. Our 5am to 9pm hours, seven days a week at all three Houston locations, solve that. Pre-dawn appointments, evening sessions, Saturday or Sunday treatment — all available. If scheduling has been the reason you’ve put this off, that obstacle is gone.
06
Comprehensive Treatment Options
Spravato is a powerful tool, but it’s not the only one. When your clinical picture benefits from a multi-modal approach, Catalyst offers complementary evidence-based treatments under the same roof:
Ketamine Therapy
Broader applications including anxiety, PTSD, chronic pain, OCD, and bipolar depression
TMS Therapy
Non-invasive magnetic brain stimulation for depression and OCD
Stellate Ganglion Block
Targeted nerve block treatment for PTSD and anxiety
Our goal is to find the right combination of treatments for your unique situation — not to fit you into a one-size-fits-all protocol.
07
Safe, Comfortable Environment
Our treatment rooms were designed specifically for the Spravato experience — not adapted from other clinical purposes. Each is private, quiet, and carefully arranged: reclinable chairs, soft adjustable lighting, warm blankets, noise-cancelling headphones. Dr. Ho’s clinical team is present and monitoring throughout every session. You’re observed, supported, and never alone during treatment.
Getting Started with Spravato Treatment in Tomball
Friendswood’s founding values — honest dealing, hard work, genuine care for the community — are still visible in how the city operates today. If you’ve applied those same values to your mental health treatment and still haven’t found the relief you needed, it’s not because you haven’t tried hard enough. It’s because you haven’t yet had access to the right tool. Spravato is that tool for a significant portion of treatment-resistant depression patients, and it’s available right now.
Call us at 800-772-1242 for your free, no-obligation phone consultation. We’ll discuss your history honestly, answer every question, and tell you clearly whether Spravato makes sense for your situation. No charge, no pressure, complete confidentiality.
Three Houston locations serve Friendswood patients, and our 5am to 9pm hours every day of the week mean treatment fits around your life. Dr. Ho and the entire Catalyst team are ready when you are.
Monday-Sunday, 6am-9pm
Free consultation
Insurance assistance
Three Houston locations
REMS-certified provider
Commonly Asked Questions
Get Help NowHow quickly does Spravato therapy work?
Many patients notice improvements within hours or days of their first treatment. The TRANSFORM-2 study showed significant improvement compared to placebo within 24 hours. This rapid action is one of Spravato’s most remarkable qualities, especially compared to traditional antidepressants that can take 4 to 8 weeks to work.
Is Spravato therapy safe?
Yes, when administered by trained medical professionals in a REMS-certified setting. Spravato underwent extensive clinical trials before FDA approval. Common side effects like dissociation, dizziness, and temporary blood pressure increases typically resolve within 1-2 hours. We monitor your vital signs throughout treatment to ensure your safety.
How many treatments will I need?
During the first month, you’ll receive Spravato twice weekly. In the second month, treatment typically decreases to once weekly. After that, most patients continue with maintenance treatments once weekly or every two weeks. The exact frequency depends on your individual response. We’ll work with you to find the schedule that keeps you feeling your best.
What does Spravato treatment feel like?
Experiences vary from person to person. Many patients describe feeling relaxed, calm, or somewhat disconnected from their surroundings. Some people experience mild visual or sensory changes. These effects are temporary and typically resolve within 1-2 hours after treatment ends. Most patients find the experience manageable and therapeutic.
Can I drive after a Spravato treatment?
No, you cannot drive yourself home after Spravato treatment, and you should not drive until the next day after a restful night’s sleep. You’ll need to arrange transportation both to and from your appointment. By the time you leave our facility after the 2-hour observation period, you’ll feel much clearer, but driving remains unsafe until the following day.
Will my insurance cover Spravato?
Many insurance plans cover Spravato for qualifying patients since it’s FDA-approved for treatment-resistant depression. Coverage varies by plan and typically requires prior authorization. Our team handles the insurance process for you, including benefits verification and prior authorization submissions.
Can I continue my current medications?
Spravato is always used alongside an oral antidepressant, so you’ll continue taking your prescribed antidepressant medication. We’ll coordinate with your prescribing physician to ensure your overall treatment plan is optimized. Some medications may require adjustment before starting Spravato, which we’ll discuss during your consultation.
Do I need a referral from my doctor?
No, you don’t need a referral to begin Spravato therapy at Catalyst Health & Wellness. However, coordination with your current prescribing physician is important since Spravato must be used alongside an oral antidepressant. We encourage communication between all members of your healthcare team.
Our Locations
Blog & insight
Insights on Healing, Growth, and Mental Wellness
June 13, 2026
FAQ: Common Questions About Ketamine Treatment Answered
If you've been researching ketamine therapy in Houston, chances are you've come across a lot of conflicting information. One article calls it a miracle cure. Another paints it as a risky party drug. Somewhere in between sits the truth, and you deserve straightforward answers before making any decision about your mental health or chronic pain…
June 10, 2026
Can Ketamine Therapy Help with Both Depression and Anxiety?
If you've spent years battling depression only to find anxiety creeping in alongside it (or vice versa), you're not imagining the connection. These two conditions show up together far more often than people realize, and the overlap can make recovery feel like trying to untangle a knot that keeps tightening. Traditional antidepressants and anti-anxiety medications…
June 7, 2026
Neuropathic Pain and Ketamine: Relief When Nerve Pain Won’t Quit
If you live with neuropathic pain, you already know it doesn't behave like ordinary pain. It burns when nothing touched you. It shocks down your leg while you're sitting still. It turns the brush of a bedsheet into something sharp. And the medications your doctor prescribed, the gabapentin, the duloxetine, maybe even opioids, take the…
Make an Appointment
Our mission is to empower individuals to overcome life’s challenges through professional psychological support.